CELL INTELLIGENCE · 肿瘤细胞治疗研究

B7-H3 在肉瘤中的临床与治疗相关性：来自系统综述的分子见解

Clinical and Therapeutic Relevance of B7-H3 in Sarcomas: Molecular Insights from a Systematic Review.

阿替利珠单抗在腺泡状软组织肉瘤中取得部分缓解并近乎完全消退广泛肺转移：一例病例报告

A partial response to atezolizumab in alveolar soft part sarcoma with near-complete resolution of extensive pulmonary metastases: a case report.

Durvalumab 和 tremelimumab 用于晚期罕见癌症患者：一项多中心、非盲、开放标签 II 期篮式试验

Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial.

度伐利尤单抗+替西木单抗治疗在唾液腺癌和 CCCO 中产生了有意义的缓解，值得在一线研究中进一步探索。

横纹肌肉瘤中的 CAR-T 细胞免疫治疗

CAR-T cell immunotherapy in rhabdomyosarcoma.

通过整合这些进展，合理设计的多模式治疗有望克服耐药机制并改善难治性横纹肌肉瘤的结局，为这种历史上难以治愈的恶性肿瘤带来希望。

肿瘤来源微囊泡促进肾脏再生与细胞保护性免疫调节

Tumor-Derived Microvesicles Promote Kidney Regeneration and Cytoprotective Immunomodulation.

跨癌种分析揭示治愈性放疗期间独特的免疫调节模式

Cross-Cancer Analysis Reveals a Distinct Pattern of Immune Modulation During Curative Radiation Therapy.

滑膜肉瘤的分子与表观遗传学肿瘤发生机制：对癌症生物学、诊断和治疗的启示

Molecular and epigenetic oncogenesis in synovial sarcoma: implications for cancer biology, diagnosis and treatment.

了解加拿大全国范围内新型高成本癌症疗法的可及性：一项针对儿科肿瘤学提供者的全国性调查

Understanding access to novel high-cost cancer therapies across Canada: a national survey of pediatric oncology providers.

加拿大儿童获得循证癌症治疗的机会仍然不均衡。统一资助、简化审批流程，以及建立加拿大 PBT 中心以减少旅途负担，将确保及时、公平地获得高成本治疗。

肿瘤来源的细胞外微囊泡治疗急性肾衰竭：一项实验研究

Tumour-Derived, Extracellular Microvesicles in the Treatment of Acute Renal Failure: An Experimental Study.

犬软组织肉瘤局部复发的临床和免疫学因素评估

Assessment of Clinical and Immunological Factors of Local Recurrence in Canine Soft Tissue Sarcoma.